Nerissa Mendoza

Title: The Innovative Contributions of Nerissa Mendoza

Introduction

Nerissa Mendoza is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on the detection and treatment of cancer, showcasing her commitment to advancing medical science.

Latest Patents

Nerissa Mendoza holds a patent for B7-H4 antibodies and methods and use thereof. This patent provides antibodies and antigen-binding fragments that specifically bind to human B7-H4. The anti-B7-H4 antibodies are useful for detecting B7-H4, and immunohistochemistry (IHC) can be employed for this purpose. Additionally, the patent outlines methods for treating cancer where increased B7-H4 has been detected, by administering a therapeutic anti-B7-H4 antibody or antigen-binding fragment.

Career Highlights

Nerissa is currently associated with Five Prime Therapeutics, Inc., where she continues to innovate in the field of cancer treatment. Her work has the potential to significantly impact patient care and improve therapeutic outcomes.

Collaborations

Some of her notable coworkers include Alessandro Palumbo and Kathy Miller, who contribute to the collaborative environment at Five Prime Therapeutics, Inc. Their combined expertise fosters innovation and drives research forward.

Conclusion

Nerissa Mendoza's contributions to biotechnology and cancer treatment through her patent on B7-H4 antibodies exemplify her dedication to improving healthcare. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.